Conference preview: Life Science IP Forum, London

In an interview with Legal IQ, which is hosting the Life Science IP Forum on November 27 and 28 in London, Ryan Zurek, managing director of IP merchant bank Ocean Tomo, described the life sciences IP market as “highly inefficient”.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

BioNTech fires shots at Moderna's next-generation vaccine

20 February 2026 The German biotech claims the newly approved vaccine infringes its mRNA patent, deepening an already complex feud with billions of dollars at stake.

Careers

Mintz gains ex-Winston & Strawn partner and ITC expert

20 February 2026 The new hire has “deep experience in high-stakes International Trade Commission proceedings”, whose specialisms include medical devices, pharma and genomics.

Americas

Abbott unit defends European protection for heart valve ‘cuff’ design

19 February 2026 An EPO appeals board has denied Boston Scientific’s bid to revoke St Jude Medical’s transcatheter aortic valve replacement (TAVR) patent, but declined to hand a complete victory to the patent owner.

More features

Emotional Perception exclusive: ‘We are now very much open for business’

The curtain closes on three major drug disputes

INTA: ‘Davos of IP’ will take London meeting to a ‘different level’

Rooted in rights: Lessons from plant patent infringement and invalidity cases

How AI will be shaped by legal and regulatory developments in 2026

Key EU and UK regulatory changes to watch for in 2026

UPC: A review of 2025 and what to expect in 2026

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

Conference preview: Life Science IP Forum, London

More on this story

Editor's picks

Editor's picks

More features